Friday, 7 February 2025

Stocks, What Happens When The Bubble Bursts? BoE, RBI Cut Rates.

Baltic Dry Index. 793 +22            Brent Crude 74.67

Spot Gold 2863               US 2 Year Yield 4.21 +0.04  

US Federal Debt. 36.448 trillion!

“The benefits of a tariff are visible. Union workers can see they are “protected”. The harm which a tariff does is invisible. It’s spread widely. There are people that don’t have jobs because of tariffs but they don’t know it.”

Milton Friedman.

It is US jobs day again, with complacent stock casinos widely expecting nothing but good news.

Economists surveyed by Dow Jones are expecting nonfarm payrolls growth of 169,000 for the month, which is lower than the 256,000 jobs added in December. The unemployment rate is also expected to hold steady at 4.1%.

While I’m not expecting the latest stock bubble to burst today or next week, I am wondering what happens when the latest stocks bubble bursts in the middle of a 1930s style trade war. Nothing good I suspect.

Asia-Pacific markets mixed as investors assess India rate cut, Japan spending data

Updated Fri, Feb 7 2025 11:54 PM EST

Asia-Pacific markets were mixed Friday as investors assessed India’s interest rate decision and Japan’s household spending data.

Australia’s S&P/ASX 200 traded flat.

Japan’s Nikkei 225 fell 0.44% and the Topix traded 0.39% lower. The country’s household spending in December rose 2.7% year on year in real terms, sharply beat Reuters’ expectations of a 0.2% rise.

South Korea’s Kospi shed 0.17%, while the small-cap Kosdaq traded around the flatline.

Hong Kong’s Hang Seng Index added 0.6%, while mainland China’s CSI 300 rose 0.77%.

The Reserve Bank of India has cut its key interest rate for the first time in nearly five years, as cooling inflation has offered room to stimulate the slowing economy.

India’s benchmark stock indexes the Nifty 50 and Sensex traded around the flatline. The Indian rupee, which has weakened to an all-time low, strengthened slightly to 87.4 against the greenback.

The Monetary Policy Committee decided to trim the repo rate by 25 basis points to 6.25%, RBI Governor Sanjay Malhotra said in a livestreamed address Friday.

The Reserve Bank of India is likely to trim the benchmark repo rate by 25 basis points to 6.25%, as it concludes its policy meeting later in the day.

Overnight in the U.S., the three major averages closed higher. The S&P 500 climbed for a third straight session on Thursday as investors weighed the latest batch of corporate earnings.

The broad market index added 0.36% to 6,083.57, while the Nasdaq Composite rose 0.51% to 19,791.99. The Dow Jones Industrial Average, however, lost 125.65 points, or 0.28%, and closed at 44,747.63.

Wall Street is now awaiting January’s jobs report, which is scheduled for release on Friday at 8:30 a.m. ET. Economists polled by Dow Jones are forecasting nonfarm payrolls growth of 169,000 for the month, less than the 256,000 jobs added in December.

Asia markets live: Reserve Bank of India decision, U.S. jobs report

Stock futures are little changed as investors brace for big payrolls report: Live updates

Updated Fri, Feb 7 20258:03 PM EST

Stock futures were slightly lower Thursday evening as January’s big jobs report loomed.

Futures tied to the Dow Jones Industrial Average lost 3 points, or 0.01%. S&P 500 futures and Nasdaq 100 futures were both near the flatline.

In extended trading, Amazon tumbled 4%. Guidance from the e-commerce giant disappointed investors, as Amazon called for revenue growth of 5% to 9% in the first quarter — its weakest growth on record. The outlook overshadowed top- and bottom-line beats in the fourth quarter.

During Thursday’s main trading session, the S&P 500 rose about 0.4%, and the Nasdaq Composite added 0.5%. It marked the third winning session in a row for the two indexes. The Dow underperformed, dipping roughly 0.3%.

All three major averages are on track to finish the week with modest gains. The S&P 500 is on pace for a 0.7% advance, while the Nasdaq is tracking for a 0.8% jump during the period. The Dow is lagging, with a week-to-date climb of about 0.5%.

Stocks have managed to rebound from Monday’s sell-off, which came after President Donald Trump over the weekend announced 10% tariffs on China. He agreed to pause 25% levies on Canada and Mexico.

The Trump administration will pose a “wild card” for the market, BD8 Capital Partners CEO Barbara Doran said Thursday on CNBC’s “Closing Bell: Overtime.”

“There’s going to be add[ed] volatility in the market, particularly with valuations where they are in general for the market,” she said.

Traders’ focus now moves toward January’s jobs report, which is slated for release on Friday at 8:30 a.m. ET. Economists surveyed by Dow Jones are expecting nonfarm payrolls growth of 169,000 for the month, which is lower than the 256,000 jobs added in December. The unemployment rate is also expected to hold steady at 4.1%.

Stock market today: Live updates

Citi Sees Gold Soaring to $3,000 on Tensions Triggered by Trump

Thu, February 6, 2025 at 4:07 PM GMT

(Bloomberg) -- Citigroup Inc. expects gold prices to hit a record $3,000 an ounce within three months, with geopolitical tensions and trade wars stoked by US President Donald Trump boosting demand for safe-haven assets.

Trump jolted markets with the prospect of tariffs that could slow economic growth, reignite inflation and disrupt global commerce. Investors will continue to seek bullion’s security and central banks are likely to keep building out their reserves, analysts including Kenny Hu wrote in a report.

“The gold bull market looks set to continue under Trump 2.0,” the Citi analysts said, citing risks such as slower growth and high interest rates.

Gold hit successive records in the past few days as concerns about the tug of war between the US and China, as well as the possibility Trump will impose duties on other nations, support bullion’s role as a store of value in uncertain times.

Citi upgraded its three-month price target for gold from $2,800 an ounce, which the precious metal has already surpassed. Spot gold slipped as much as 1.2% to $2,834.26 an ounce on Thursday.

The bank also said that an appreciating US dollar will increase the incentive for central banks from emerging economies to boost gold holdings in order to support their own currencies, while investors will turn both to physical gold and exchange-traded funds.

Trade-war fears have also led dealers in London to shift metal to the US, fearing the possibility that bullion won’t be excluded from potential tariffs. Premiums as of Wednesday implied a roughly 20% chance of Trump including gold in a 10% blanket global tariff, Citi said.

More

Citi Sees Gold Soaring to $3,000 on Tensions Triggered by Trump

In other news.

Bank of England cuts interest rates despite looming inflation surge

Thursday 06 February 2025 12:04 pm  |  Updated:  Thursday 06 February 2025 12:21 pm

The Bank of England cut interest rates by 25 basis points on Thursday, even though rate-setters expect to see a significant rise in inflation over the coming year

Seven members of the Bank’s Monetary Policy Committee (MPC) backed the decision, while two – Swati Dhingra and Catherine Mann – voted for a larger 50 basis point cut. 

The decision means that the benchmark Bank Rate stands at 4.50 per cent, down from a peak of 5.25 per cent.

While investors had expected the Bank to cut rates, many thought that at least one member of the MPC, likely Mann, would have voted to hold rates steady. 

Andrew Bailey, the Bank’s Governor, said: “We’ll be monitoring the UK economy and global developments very closely and taking a gradual and careful approach to reducing rates further,” 

The vote split suggests the MPC is increasingly concerned with weakness in the economy, meaning they will look through the anticipated resurgence in inflation. 

Inflation will rise to a peak of 3.7 per cent in the third quarter of this year, according to the Bank’s latest forecasts, a significant upgrade on its previous assessment of 2.8 per cent. 

The increase will largely be driven by higher global energy prices, which have surged since November. Regulated prices like water bills and bus fares will also play a role, the forecasts suggest. 

However, the MPC continued to predict that the Budget tax hikes would only have a limited pass-through to consumer prices. 

Bank of England warns on inflation

Although the headline rate will rise, MPC members noted that progress on underlying inflation has continued in recent months. 

Services inflation has fallen further than expected, while wage growth is expected to “slow significantly” by the end of 2025, the MPC said. 

It predicted that the pickup in headline inflation would “not lead to additional second-round effects” which would derail progress on underlying inflation. 

Inflation will eventually return to target in the final quarter of 2027, two quarters later than the Bank predicted in November. 

More

Bank of England cuts interest rates despite looming inflation surge

Bank of England’s Bailey says UK can’t avoid U.S. tariff impact — even if it’s not in the direct firing line

Published Thu, Feb 6 2025 11:01 AM EST Updated Thu, Feb 6 2025 11:59 AM EST

Even if the U.K. is not the “direct recipient” of potential tariffs imposed by the U.S., “it will have an effect,” Bank of England Governor Andrew Bailey said Thursday.

If tariffs are announced, their effect on the global economic growth and inflation would need to be looked at, Bailey told CNBC’s Steve Sedgwick.

“Now I think that in terms of growth in the world economy, if this will lead to a, you know, fragmentation of the world economy, that is not good for growth,” Bailey said. “The impact on inflation is more ambiguous, because it depends upon what other countries do in response, it depends on what the consequences of those actions and reactions are for trade,” he added.

U.S. President Donald Trump has warned that the U.K. could be in line for tariffs, but has also indicated a deal could potentially be struck. Trump last week announced tariffs on goods imported from China, Canada and Mexico, before pausing planned duties on imports from the two latter economies.

Bailey on Thursday also noted that the U.K. “does not have a substantial trade imbalance with the U.S.”

The U.S. was the U.K.’s biggest trading partner in the year to September 2024, accounting for over 17% of total U.K. trade, according to official data.

Depending on which figures you look at, the two countries either have a small trade deficit or surplus. What’s important for Trump, though — who has expressed dissatisfaction when the U.S. exports less to a country than it imports — is the numbers are almost balanced.

Bailey also pointed out that services are a large part of U.K. trade, which classic tariffs do not affect in the same way as other goods.

More

Bank of England's Bailey says UK can't avoid U.S. tariff impact

Global Inflation/Stagflation/Recession Watch.

Given our Magic Money Tree central banksters and our spendthrift politicians, inflation now needs an entire section of its own.

China says will protect its own interests in face of U.S. ‘bullying’

Published Thu, Feb 6 2025 3:53 AM EST

BEIJING — China has toughened its tone following the Trump administration’s opening salvo of trade tariffs.

“In the face of one-sided acts of bullying, [China] will definitely take necessary measures to firmly protect its own rights and interests,” Chinese Ministry of Commerce Spokesperson He Yongqian told reporters Thursday, according to a CNBC translation.

She added that China would not provoke trade disputes and remained ready to resolve problems through discussions. Beijing’s official commentary previously emphasized the willingness to negotiate.

China’s Ministry of Foreign Affairs Spokesperson Lin Jian struck conveyed a similar mood on Wednesday.

“China firmly deplores and opposes the move of the U.S. to levy a 10 percent additional tariff on Chinese imports under the pretext of the fentanyl issue,” he said, according to an official English translation. “The measures China has taken are what’s needed for safeguarding our legitimate rights and interests.”

CNBC has reached out to the U.S. State Department for comment.

The official remarks came just days after the U.S. announced 10% tariffs on Chinese goods, to which the Chinese side on Tuesday retaliated with its own duties of up to 15% on U.S. liquefied natural gas and select products, starting Feb. 10.

The U.S. also halted a so-called de minimis exemption, making it more expensive for Chinese e-commerce merchants to ship products directly to U.S. consumers.

Ministry of Commerce spokesperson He on Thursday urged the U.S. to create a “fair and predictable” environment for cross-border e-commerce.

China says will protect its own interests in face of U.S. 'bullying'

Covid-19 Corner

This section will continue until it becomes unneeded.

New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.

Feb 5 2025

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA). Ocugen, a U.S.-based biotechnology company, licensed the innovative technology from WashU in 2022.

The trial will be sponsored and conducted by the National Institute of Allergy and Infectious Diseases (NIAID), of the National Institutes of Health (NIH). The FDA's action is a critical first step toward initiation of the phase 1 trial, planned for this spring.

While cases of COVID-19 have fallen dramatically since the early years of the pandemic, the virus continues to circulate and still causes significant illnesses and deaths. The nasal vaccine technology is designed to induce strong immunity in the nose and upper respiratory tract, right where the virus enters the body, thereby potentially stopping transmission of the virus in addition to reducing serious illness and death. Most COVID-19 vaccines are injected into the arm or leg, and while they are effective at reducing illness and death, they do not halt transmission. The new trial will evaluate the safety and efficacy of the vaccine administered via two routes: inhaled into the lungs and sprayed into the nose.

A version of the vaccine has been available in India since 2022 through a licensing agreement between WashU and the Indian biotechnology company Bharat Biotech.

The Phase 1 trial is funded through Project NextGen, a U.S. government agency initiative to develop next-generation COVID-19 vaccines and therapeutics through public-private partnerships.

The trial will enroll 80 adults ages 18 to 64 years. Participants will be randomly assigned to one of four groups: low-dose intranasal, high-dose intranasal, low-dose inhaled and high-dose inhaled. The primary aim of the trial is to determine safety, but researchers will also assess immunogenicity by measuring antibody production and efficacy by determining the number of breakthrough COVID-19 cases.

The investigational nasal vaccine was co-developed by WashU Medicine scientists Michael S. Diamond, MD, PhD, the Herbert S. Gasser Professor of Medicine and the co-director of the Center for Vaccines & Immunity to Microbial Pathogens, and David T. Curiel, MD, PhD, the Distinguished Professor of Radiation Oncology, along with members of their laboratories.

Diamond and Curiel inserted a gene from SARS-CoV-2, the virus that causes COVID-19, into a harmless virus known as an adenovirus. The adenovirus carries the SARS-CoV-2 protein into the nose, enabling people to mount an immune defense against the SARS-CoV-2 virus without becoming sick.

"It is gratifying to see the vaccine that we conceived, designed and conducted initial testing on move closer to becoming available here in the U.S.," said Diamond, also a professor of molecular microbiology and of pathology & immunology.

Diamond and Curiel's early studies at WashU Medicine showed that nasal delivery of this vaccine creates a strong immune response throughout the body, especially in the nose and respiratory tract. In animal studies conducted in 2020 and 2021, the nasal vaccine entirely prevented infection from taking hold in the nose and lungs - suggesting that vaccinated individuals would be able to fend off the virus before it could multiply and cause an infection. Last year, Jacco Boon, PhD, a professor of medicine, of molecular microbiology and of pathology & immunology at WashU Medicine, showed that hamsters vaccinated with the nasal COVID-19 vaccine and subsequently infected did not pass the virus on to others, breaking the cycle of transmission.

"All effective vaccines reduce sickness and death, but COVID-19 vaccination through the nose and mouth also seems to reduce transmission," said Curiel, also a professor of medicine and of obstetrics & gynecology. "This capability is critical in slowing the spread of respiratory infections such as COVID-19 through a population, and the same vaccine technology can be designed to target other COVID-19 strains as well as influenza and other respiratory viruses."

New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.

Technology Update.

With events happening fast in the development of solar power and graphene, among other things, I’ve added this section. Updates as they get reported.

DeepSeek has rattled large AI players — but smaller chip firms see it as a force multiplier

Published Thu, Feb 6 2025 10:40 PM EST

DeepSeek has rattled the U.S.-led AI ecosystem with its latest model, shaving hundreds of billions in chip leader Nvidia’s market cap. While the sector leaders grapple with the fallout, smaller AI companies see an opportunity to scale with the Chinese startup.

Several AI-related firms told CNBC that DeepSeek’s emergence is a “massive” opportunity for them, rather than a threat. 

“Developers are very keen to replace OpenAI’s expensive and closed models with open source models like DeepSeek R1...” said Andrew Feldman, CEO of artificial intelligence chip startup Cerebras Systems.

The company competes with Nvidia’s graphic processing units and offers cloud-based services through its own computing clusters. Feldman said the release of the R1 model generated one of Cerebras’ largest-ever spikes in demand for its services. 

“R1 shows that [AI market] growth will not be dominated by a single company — hardware and software moats do not exist for open-source models,” Feldman added. 

Open source refers to software in which the source code is made freely available on the web for possible modification and redistribution. DeepSeek’s models are open source, unlike those of competitors such as OpenAI.

DeepSeek also claims its R1 reasoning model rivals the best American tech, despite running at lower costs and being trained without cutting-edge graphic processing units, though industry watchers and competitors have questioned these assertions.

“Like in the PC and internet markets, falling prices help fuel global adoption. The AI market is on a similar secular growth path,” Feldman said. 

Inference chips 

DeepSeek could increase the adoption of new chip technologies by accelerating the AI cycle from the training to “inference” phase, chip start-ups and industry experts said.

Inference refers to the act of using and applying AI to make predictions or decisions based on new information, rather than the building or training of the model.

“To put it simply, AI training is about building a tool, or algorithm, while inference is about actually deploying this tool for use in real applications,” said Phelix Lee, an equity analyst at Morningstar, with a focus on semiconductors.  

While Nvidia holds a dominant position in GPUs used for AI training, many competitors see room for expansion in the “inference” segment, where they promise higher efficiency for lower costs.

More

DeepSeek can be a force multiplier for smaller AI chip firms

Graphene Oxide Coating Boosts Maize Seedling Growth

4 February 2025

A recent study published in Scientific Reports explores using graphene oxide (GO) as a seed coating to enhance maize seedling growth. With the growing demand for increased food production, particularly in the face of challenging climatic conditions, researchers are investigating innovative methods to improve crop yields. Maize, a key staple crop, is highly influenced by seed quality and environmental factors, making advancements like GO-based treatments particularly relevant.

Background

GO is known for its unique structural and chemical properties, making it an attractive candidate for nanotechnology applications, including agriculture. Its high surface area, mechanical strength, and ability to interact with biological molecules offer potential benefits for plant growth. Previous studies suggest that nanomaterials can enhance seed germination, improve nutrient uptake, and increase plant resilience against stressors such as drought and pests. Carbon-based nanomaterials like GO are gaining attention for their non-toxic and environmentally friendly characteristics in agricultural applications.

Related Stories

The researchers investigated the effects of different GO concentrations on maize seedling growth under controlled conditions. Maize seeds were coated with a composite formulation containing commercial seed treatment agents and varying GO concentrations: 0 g/L (control), 22 g/L (T1), 44 g/L (T2), 66 g/L (T3), and 88 g/L (T4). The coated seeds were sown in polyethylene basins filled with soil characterized by specific physical and chemical properties, including pH and nutrient content.

The study used a completely randomized design with three replicates per treatment group. After 30 days of cultivation in a greenhouse, key growth parameters such as plant height, stem diameter, root length, fresh weight, and dry weight were measured. Raman spectroscopy and scanning electron microscopy (SEM) were also used to analyze the GO structure and its effects on seedling morphology.

Results and Discussion

The results showed that GO seed coatings significantly improved maize seedling growth, with notable increases in total root length. Compared to the control group, treatments T1, T2, T3, and T4 exhibited root length increases of 23.82 %, 79.34 %, 48.79 %, and 20.98 %, respectively. The T2 treatment (44 g/L GO) demonstrated the highest increase in root length.

Aboveground growth measurements—such as stem diameter, fresh weight, and dry weight—followed a similar trend, increasing up to T2 before declining at higher concentrations. This suggests an optimal GO concentration for stimulating growth, beyond which excessive amounts may hinder physiological processes. The study emphasizes the importance of optimizing GO levels for maximum benefits.

The enhanced root development observed in GO-treated seedlings is likely due to improved water and nutrient absorption. GO’s physicochemical properties may also influence plant signaling pathways that promote growth. Interestingly, while root development showed significant differences across treatments, plant height remained relatively unchanged, indicating that root systems play a crucial role in early seedling establishment.

More

Graphene Oxide Coating Boosts Maize Seedling Growth

Next, the world global debt clock. Nations debts to GDP compared.

World Debt Clocks (usdebtclock.org)

Another weekend and what would President Trump buy if he actually does get his Sovereign Wealth Fund? (Given that the USA runs deficits it would actually be a Sovereign Debt Fund.)  

Greenland and the Panama Canal come to mind, but Gaza? Gold and silver? Bitcoin? Nvidia? AI stocks? Diego Garcia? Finally, the big one, Canada?  Buying Canada would at least link Alaska to the rest of the USA except Hawaii, although given Canada’s winters, how long before most former Canadians were living in Florida, Arizona and California?

Have a great weekend everyone.

“For example, the supporters of tariffs treat it as self-evident that the creation of jobs is a desirable end, in and of itself, regardless of what the persons employed do. That is clearly wrong. If all we want are jobs, we can create any number–for example, have people dig holes and then fill them up again, or perform other useless tasks. Work is sometimes its own reward. Mostly, however, it is the price we pay to get the things we want. Our real objective is not just jobs but productive jobs–jobs that will mean more goods and services to consume.”

Milton Friedman.

No comments:

Post a Comment